Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft.

Trial statusNot yet recruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age20-50
SponsorAin Shams University

About this trial

This study will be conducted to compare the effect of Erythropoietin gel mixed with xenograft versus xenograft alone in grafting the jumping gap around immediate implant.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Both genders aged from 20 to 50 years.

Systemically free patients as evidenced by Burket's oral health history questionnaire.

Patients need the extraction of non-restorable maxillary tooth in esthetic zone and the possibility of immediate placement of implants on the same site with Intact labial plate and interproximal bone levels (socket type 1).

Gap space of more than 2 mm between the implant and buccal bone.

Disqualifiers

Smokers.

Pregnant or lactating females.

Acute infection at the implant site

Patients under any medication that affects the healing.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Erythropoetin gel mixed with xenogenic bone graft

    Drug

    Patients with EPO gel mixed with xenogenic bone graft in the jumping gap of immediate implant.

  • Xenogenic bone with gelling aget CMC ( carboxymethyl cellulose)

    Other intervention

    Patients with xenogenic bone graft and gelling agent in the jumping gap of immediate implant.

Treatment groups

26 Participants
are divided into 2 treatment groups
Group A: Patients with EPO gel mixed with xenogenic bone graftExperimental treatment 1 intervention
Group B: Patients with xenogenic bone graft and gelling agentActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Radiographic assessment

Radiographic assessment of alveolar bone width by CBCT

Time frame
0-6 months

Secondary outcomes

1

Radiographic assessment

Radiographic assessment of alveolar bone height by CBCT

Time frame
0-6 months
2

Clinical assessment

Clinical assessment (Soft tissue height and thickness)

Time frame
0-3-6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: